Global Lung Cancer Surgery Market: Overview
Lung cancer is also known as lung carcinoma. It is malignant in nature and undergoes uncontrolled cell growth in the lung tissues. It grows beyond the lung and affects other parts of the body. It is caused due to uncontrolled growth of the abnormal cancerous cells in lungs. These cancerous cells undergo rapid division and affect the normal functioning of lung, which means it stops providing oxygen to the bloodstream. Primary lung cancer is also known as carcinomas. It occurs in the lungs whereas secondary lung cancer begins in other parts of the body.
Global Lung Cancer Surgery Market: Growth Factors
Major driving factor of the global lung cancer surgery market is genetic inheritance and inhalation of carcinogenic substances. Some of the other growth factors include arsenic, tobacco, asbestos, and radiations such as UV rays and X-rays cause carcinogens. Owing to inhalation of carcinogens substances, smoking, and genetic inheritance, chances of lung cancer increases, which in turn positively impacts the global market growth.
Global Lung Cancer Surgery Market: Segmentation
The global lung cancer surgery market is classified on the basis of microscopic observation as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Of these, non-small cell lung cancer is the leading microscopic observation segment in the global lung cancer surgery market. Non-small cell lung cancer is further sub-segmented as squamous cell carcinoma, large cell undifferentiated carcinoma, adenocarcinoma, and bronchioalveolar. Based on lung surgery, the global market is bifurcated as segmentectomy, sleeve resection, pneumonectomy, and lobectomy. In pneumonectomy, the entire lung is removed, while tiny wedge shaped lung piece is removed in segmentectomy. However, cancer affected lobe is removed in the lobectomy. In sleeve resection, removal of cancerous part of the bronchus is done and is reconnected to the healthy part of the body.
Global Lung Cancer Surgery Market: Regional Analysis
Geographically, the lung cancer surgery market is fragmented as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is the leading region in the global market for lung cancer surgery, where expensive robotic surgeries are carried out, which is anticipated to contribute to the growth of the global lung cancer surgery market in the future.
Global Lung Cancer Surgery Market: Competitive Players
Some of the key players dominating the global lung cancer surgery market are Neomend Inc., Siemens Healthcare, Ethicon Endo-Surgery Inc., Olympus Cor, and Richard Wolf GmbH.
Global Lung Cancer Surgery Market: Regional Segment Analysis
What Report Provides